Literature DB >> 15861930

The complexity of achieving anticoagulation control in the face of warfarin-phenytoin interaction: an Asian case report.

Yahaya Hassan1, Ahmed Awaisu, Noorizan Abd Aziz, Omar Ismail.   

Abstract

Phenytoin has been reported to have major interactions with warfarin. Phenytoin induces warfarin's metabolism. However, there are many case reports which provide conflicting conclusions. Here, we report a case of a 65-year-old man with mechanical heart valve on chronic warfarin therapy who experienced persistent fluctuations of INR and bleeding secondary to probable warfarin-phenytoin interactions. The patient's anticoagulation clinic visits prior to hospitalization were thoroughly evaluated and we continued to follow-up the case for 3 months post-hospitalization. The reported interaction could be reasonably explained from the chronology of events and the pattern of INR fluctuations whenever phenytoin was either added or discontinued from his drug regimen.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15861930     DOI: 10.1007/s11096-004-5150-3

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  13 in total

Review 1.  Managing oral anticoagulant therapy.

Authors:  J Ansell; J Hirsh; J Dalen; H Bussey; D Anderson; L Poller; A Jacobson; D Deykin; D Matchar
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

2.  CYP2C9 genotypes and dose requirements during the induction phase of oral anticoagulant therapy.

Authors:  Flora Peyvandi; Marta Spreafico; Simona Maria Siboni; Marco Moia; Pier Mannuccio Mannucci
Journal:  Clin Pharmacol Ther       Date:  2004-03       Impact factor: 6.875

Review 3.  A review of enzyme induction of warfarin metabolism with recommendations for patient management.

Authors:  J S Cropp; H I Bussey
Journal:  Pharmacotherapy       Date:  1997 Sep-Oct       Impact factor: 4.705

4.  Pharmacokinetic consequences of drug displacement from blood and tissue proteins.

Authors:  J J MacKichan
Journal:  Clin Pharmacokinet       Date:  1984-01       Impact factor: 6.447

5.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

6.  Interindividual variability in sensitivity to warfarin--Nature or nurture?

Authors:  R Loebstein; H Yonath; D Peleg; S Almog; M Rotenberg; A Lubetsky; J Roitelman; D Harats; H Halkin; D Ezra
Journal:  Clin Pharmacol Ther       Date:  2001-08       Impact factor: 6.875

7.  Contribution of age, body size, and CYP2C9 genotype to anticoagulant response to warfarin.

Authors:  Farhad Kamali; Tayyaba Irfan Khan; Barry P King; Richard Frearson; Patrick Kesteven; Peter Wood; Ann K Daly; Hilary Wynne
Journal:  Clin Pharmacol Ther       Date:  2004-03       Impact factor: 6.875

Review 8.  Interactions of warfarin with drugs and food.

Authors:  P S Wells; A M Holbrook; N R Crowther; J Hirsh
Journal:  Ann Intern Med       Date:  1994-11-01       Impact factor: 25.391

9.  Temporary discontinuation of warfarin therapy: changes in the international normalized ratio.

Authors:  R H White; T McKittrick; R Hutchinson; J Twitchell
Journal:  Ann Intern Med       Date:  1995-01-01       Impact factor: 25.391

10.  Optimal oral anticoagulant therapy in patients with mechanical heart valves.

Authors:  S C Cannegieter; F R Rosendaal; A R Wintzen; F J van der Meer; J P Vandenbroucke; E Briët
Journal:  N Engl J Med       Date:  1995-07-06       Impact factor: 91.245

View more
  4 in total

Review 1.  Drug Interactions in Neurocritical Care.

Authors:  Brian Spoelhof; Salia Farrokh; Lucia Rivera-Lara
Journal:  Neurocrit Care       Date:  2017-10       Impact factor: 3.210

2.  Warfarin Interaction With Hepatic Cytochrome P-450 Enzyme-Inducing Anticonvulsants.

Authors:  Nathan P Clark; Kim Hoang; Thomas Delate; John R Horn; Daniel M Witt
Journal:  Clin Appl Thromb Hemost       Date:  2017-01-25       Impact factor: 2.389

Review 3.  Clinically relevant drug interactions with antiepileptic drugs.

Authors:  Emilio Perucca
Journal:  Br J Clin Pharmacol       Date:  2006-03       Impact factor: 4.335

4.  Warfarin and phenytoin drug interaction with possible purple glove syndrome.

Authors:  Carolyn S Hunter; Stephanie V Phan
Journal:  J Pharmacol Pharmacother       Date:  2016 Apr-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.